Suppr超能文献

乳房假体置入后乳房血肿的发生率。

Incidence of breast hematoma after placement of breast prostheses.

机构信息

Temple, Texas From the Division of Plastic Surgery, Department of Surgery, Scott & White Healthcare.

出版信息

Plast Reconstr Surg. 2012 Mar;129(3):413e-420e. doi: 10.1097/PRS.0b013e3182402ce0.

Abstract

BACKGROUND

Prosthetic breast implants are frequently used by plastic surgeons for reconstructive and aesthetic procedures. One known complication of the procedure is postoperative breast hematoma. However, the incidence and risk factors of this problem are not fully characterized.

METHODS

A retrospective analysis was performed of a prospectively collected patient medical record database based on procedure codes to identify breast hematomas and possible risk factors over a 12-year period from November of 1996 to October of 2008.

RESULTS

One thousand nine hundred thirty-six operations were performed on 3474 breasts with prosthetic implants used. Average patient follow-up was 48.9 months, with 32 hematomas identified following 32 operations. The latest hematoma identified was 21 months after the procedure. Hematomas were identified on average 37 days after the operation.

CONCLUSIONS

In the authors' experience, postoperative breast hematomas after prosthetic implant placement occur in 0.92 percent of breast prostheses placed. No individual surgical approach is associated with the occurrence of breast hematomas. Hematomas are not statistically associated with any measured patient or surgically defined characteristic. Specifically, no statistical significance was shown for larger implant size, reoperation, operative indication, type of surgery, or implant type as an independent risk factor.

CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

摘要

背景

整形外科医生经常使用假体乳房植入物进行重建和美容手术。该手术已知的一种并发症是术后乳房血肿。然而,该问题的发病率和危险因素尚未完全明确。

方法

对 1996 年 11 月至 2008 年 10 月期间 12 年来使用假体植入物的前瞻性收集的患者病历数据库进行回顾性分析,以确定乳房血肿和可能的危险因素。

结果

在 3474 个乳房中进行了 1936 次手术,其中使用了假体植入物。平均患者随访时间为 48.9 个月,在 32 次手术中发现了 32 个血肿。最晚发现的血肿发生在手术后 21 个月。血肿平均在手术后 37 天发现。

结论

在作者的经验中,假体植入后发生的术后乳房血肿在放置的乳房假体中占 0.92%。没有任何特定的手术方法与乳房血肿的发生有关。血肿与任何测量的患者或手术定义的特征均无统计学关联。具体来说,在大的植入物大小、再次手术、手术适应证、手术类型或植入物类型作为独立危险因素方面,未显示出统计学意义。

临床问题/证据水平:风险,III 级。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验